|
Company:
|
PAVMED INC. (PAVM)
|
|
Form Type:
|
DEF 14A
|
|
Filing Date:
|
6/11/2020
|
|
CIK:
|
0001624326
|
|
Address:
|
ONE GRAND CENTRAL PLACE
SUITE 4600
|
|
City, State, Zip:
|
NEW YORK, New York 10165
|
|
Telephone:
|
212-949-4319
|
|
Fiscal Year:
|
12/31
|
|
|
|
|
|
Last Trade
|
Last Trade:
$2.04
|
Change:
-0.24 (-10.53%)
|
Trade Time:
Jan 27
|
Market Cap:
$146.68M
|
|
|
|
|
|
|
Description of Business
|
|
PAVmed is a highly-differentiated multi-product technology medical device
company organized to advance a broad pipeline of innovative medical technologies
from concept to commercialization, employing a business model focused on capital
efficiency and speed to market. Since inception on June 26, 2014, the Company's
activities have focused on advancing its lead products towards regulatory
approval and commercialization, protecting its intellectual property, and
building its corporate infrastructure and management team. The Company operates
in one segment as a medical device company with four operating divisions which
include GI Health, Minimally Invasive Interventions, Infusion Therapy, and
Emerging Innovations. As resources permit, we will continue to explore internal
and external innovations that fulfill our project selection criteria without
limiting ourselves to any target specialty or condition.
|
|
|
|